NATERA, INC. Operating Lease, Payments
NATERA, INC. (NTRA) reported Operating Lease, Payments of $12.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:OperatingLeasePayments · last filed 2026-08-07
- NATERA, INC. operating lease, payments for the quarter ending 2026-06-30 was $6.10M, a 27.08% increase year-over-year.
- NATERA, INC. operating lease, payments for the quarter ending 2026-03-31 was $5.90M, a 31.11% increase year-over-year.
- NATERA, INC. operating lease, payments for the quarter ending 2025-12-31 was $5.60M, a 30.23% increase year-over-year.
- NATERA, INC. operating lease, payments for the quarter ending 2025-09-30 was $4.90M, a 16.67% increase year-over-year.
- NATERA, INC. operating lease, payments for fiscal 2025 was $19.80M, a 17.86% increase from fiscal 2024.
- NATERA, INC. operating lease, payments for fiscal 2024 was $16.80M, a 35.48% increase from fiscal 2023.
- NATERA, INC. operating lease, payments for fiscal 2023 was $12.40M, a 31.91% increase from fiscal 2022.
- NATERA, INC. operating lease, payments for fiscal 2022 was $9.40M, a 8.74% decline from fiscal 2021.
| Period end | Operating Lease, Payments 3 month | Operating Lease, Payments 3 month as first filed | Operating Lease, Payments 6 month | Operating Lease, Payments 6 month as first filed | Operating Lease, Payments 9 month | Operating Lease, Payments 9 month as first filed | Operating Lease, Payments 12 month | Operating Lease, Payments 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $6.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $12.00M 10-Q · filed 2026-08-07 | $17.60M derived: sum of 3 quarters · filed 2026-08-07 | $22.50M derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2026-03-31 | $5.90M 10-Q · filed 2026-05-08 | $11.50M derived: sum of 2 quarters · filed 2026-05-08 | $16.40M derived: sum of 3 quarters · filed 2026-05-08 | $21.20M derived: sum of 4 quarters · filed 2026-05-08 | ||||
| 2025-12-31 | $5.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $10.50M derived: sum of 2 quarters · filed 2026-02-27 | $15.30M derived: sum of 3 quarters · filed 2026-02-27 | $19.80M 10-K · filed 2026-02-27 | ||||
| 2025-09-30 | $4.90M 10-Q · filed 2025-11-07 | $9.70M derived: sum of 2 quarters · filed 2025-11-07 | $14.20M 10-Q · filed 2025-11-07 | $18.50M derived: sum of 4 quarters · filed 2026-05-08 | ||||
| 2025-06-30 | $4.80M 10-Q · filed 2025-08-08 | $9.30M 10-Q · filed 2026-08-07 | $13.60M derived: sum of 3 quarters · filed 2026-05-08 | $17.80M derived: sum of 4 quarters · filed 2026-05-08 | ||||
| 2025-03-31 | $4.50M 10-Q · filed 2026-05-08 | $8.80M derived: sum of 2 quarters · filed 2026-05-08 | $13.00M derived: sum of 3 quarters · filed 2026-05-08 | $17.10M derived: sum of 4 quarters · filed 2026-05-08 | ||||
| 2024-12-31 | $4.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $8.50M derived: sum of 2 quarters · filed 2026-02-27 | $12.60M derived: sum of 3 quarters · filed 2026-02-27 | $16.80M 10-K · filed 2026-02-27 | ||||
| 2024-09-30 | $4.20M 10-Q · filed 2025-11-07 | $8.30M derived: sum of 2 quarters · filed 2025-11-07 | $12.50M 10-Q · filed 2025-11-07 | $16.40M derived: sum of 4 quarters · filed 2026-02-27 | ||||
| 2024-06-30 | $4.10M 10-Q · filed 2025-08-08 | $8.30M 10-Q · filed 2025-08-08 | $12.20M derived: sum of 3 quarters · filed 2026-02-27 | $15.40M derived: sum of 4 quarters · filed 2026-02-27 | ||||
| 2024-03-31 | $4.10M 10-Q · filed 2025-05-09 | $8.10M derived: sum of 2 quarters · filed 2026-02-27 | $11.30M derived: sum of 3 quarters · filed 2026-02-27 | $14.30M derived: sum of 4 quarters · filed 2026-02-27 | ||||
| 2023-12-31 | $4.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $7.20M derived: sum of 2 quarters · filed 2026-02-27 | $10.20M derived: sum of 3 quarters · filed 2026-02-27 | $12.40M 10-K · filed 2026-02-27 | ||||
| 2023-09-30 | $3.20M 10-Q · filed 2024-11-12 | $6.20M derived: sum of 2 quarters · filed 2024-11-12 | $8.40M 10-Q · filed 2024-11-12 | $8.42M 10-Q · filed 2023-11-09 | $10.59M derived: sum of 4 quarters · filed 2025-02-28 | |||
| 2023-06-30 | $3.00M 10-Q · filed 2024-08-09 | $5.20M 10-Q · filed 2024-08-09 | $5.20M 10-Q · filed 2023-08-04 | $7.39M derived: sum of 3 quarters · filed 2025-02-28 | $9.09M derived: sum of 4 quarters · filed 2025-02-28 | |||
| 2023-03-31 | $2.20M 10-Q · filed 2024-05-10 | $2.18M 10-Q · filed 2023-05-10 | $4.39M derived: sum of 2 quarters · filed 2025-02-28 | $6.09M derived: sum of 3 quarters · filed 2025-02-28 | $8.89M derived: sum of 4 quarters · filed 2025-02-28 | |||
| 2022-12-31 | $2.19M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $3.89M derived: sum of 2 quarters · filed 2025-02-28 | $6.69M derived: sum of 3 quarters · filed 2025-02-28 | $9.40M 10-K · filed 2025-02-28 | $9.38M 10-K · filed 2023-03-01 | |||
| 2022-09-30 | $1.70M 10-Q · filed 2023-11-09 | $4.50M derived: sum of 2 quarters · filed 2023-11-09 | $7.21M 10-Q · filed 2023-11-09 | $9.97M derived: sum of 4 quarters · filed 2024-02-29 | ||||
| 2022-06-30 | $2.80M 10-Q · filed 2023-08-04 | $5.53M 10-Q · filed 2023-08-04 | $8.27M derived: sum of 3 quarters · filed 2024-02-29 | $10.87M derived: sum of 4 quarters · filed 2024-02-29 | ||||
| 2022-03-31 | $2.77M 10-Q · filed 2023-05-10 | $5.47M derived: sum of 2 quarters · filed 2024-02-29 | $8.07M derived: sum of 3 quarters · filed 2024-02-29 | $10.57M derived: sum of 4 quarters · filed 2024-02-29 | ||||
| 2021-12-31 | $2.70M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $5.30M derived: sum of 2 quarters · filed 2024-02-29 | $7.80M derived: sum of 3 quarters · filed 2024-02-29 | $10.30M 10-K · filed 2024-02-29 | ||||
| 2021-09-30 | $2.60M 10-Q · filed 2022-11-09 | $5.10M derived: sum of 2 quarters · filed 2022-11-09 | $7.60M 10-Q · filed 2022-11-09 | $7.60M 10-Q · filed 2021-11-05 | $9.98M derived: sum of 4 quarters · filed 2023-03-01 | |||
| 2021-06-30 | $2.50M 10-Q · filed 2022-08-05 | $4.99M 10-Q · filed 2022-08-05 | $5.00M 10-Q · filed 2021-08-06 | $7.38M derived: sum of 3 quarters · filed 2023-03-01 | $9.58M derived: sum of 4 quarters · filed 2023-03-01 | |||
| 2021-03-31 | $2.49M 10-Q · filed 2022-05-06 | $2.50M 10-Q · filed 2021-05-07 | $4.88M derived: sum of 2 quarters · filed 2023-03-01 | $7.08M derived: sum of 3 quarters · filed 2023-03-01 | $9.28M derived: sum of 4 quarters · filed 2023-03-01 | |||
| 2020-12-31 | $2.39M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $4.59M derived: sum of 2 quarters · filed 2023-03-01 | $6.79M derived: sum of 3 quarters · filed 2023-03-01 | $8.99M 10-K · filed 2023-03-01 | $9.00M 10-K · filed 2021-02-26 | |||
| 2020-09-30 | $2.20M 10-Q · filed 2021-11-05 | $4.40M derived: sum of 2 quarters · filed 2021-11-05 | $6.60M 10-Q · filed 2021-11-05 | $8.60M derived: sum of 4 quarters · filed 2022-02-25 | ||||
| 2020-06-30 | $2.20M 10-Q · filed 2021-08-06 | $4.40M 10-Q · filed 2021-08-06 | $6.40M derived: sum of 3 quarters · filed 2022-02-25 | $8.60M derived: sum of 4 quarters · filed 2022-02-25 | ||||
| 2020-03-31 | $2.20M 10-Q · filed 2021-05-07 | $4.20M derived: sum of 2 quarters · filed 2022-02-25 | $6.40M derived: sum of 3 quarters · filed 2022-02-25 | $8.50M derived: sum of 4 quarters · filed 2022-02-25 | ||||
| 2019-12-31 | $2.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $4.20M derived: sum of 2 quarters · filed 2022-02-25 | $6.30M derived: sum of 3 quarters · filed 2022-02-25 | $8.60M 10-K · filed 2022-02-25 | ||||
| 2019-09-30 | $2.20M 10-Q · filed 2019-11-08 | $4.30M derived: sum of 2 quarters · filed 2019-11-08 | $6.60M 10-Q · filed 2020-11-06 | |||||
| 2019-06-30 | $2.10M 10-Q · filed 2019-08-09 | $4.40M 10-Q · filed 2020-08-07 | ||||||
| 2019-03-31 | $2.10M 10-Q · filed 2020-05-08 | |||||||
| 2018-12-31 | $7.90M 10-K · filed 2021-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |